DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,630,407 | -20.7% | 3,306,965 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $37,374,605 | +23.9% | 3,322,187 | +26.8% | 0.00% | 0.0% |
| Q1 2023 | $30,173,428 | -0.6% | 2,619,221 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $30,349,783 | -5.4% | 2,618,618 | +3.7% | 0.00% | 0.0% |
| Q3 2022 | $32,069,000 | +88.6% | 2,525,067 | +2.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000,000 | -25.4% | 2,474,498 | +4.6% | 0.00% | 0.0% |
| Q1 2022 | $22,797,000 | -20.5% | 2,364,981 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $28,671,000 | -11.2% | 2,411,397 | +21.3% | 0.00% | 0.0% |
| Q3 2021 | $32,288,000 | -22.2% | 1,988,152 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $41,494,000 | +115.2% | 1,972,208 | +58.8% | 0.00% | 0.0% |
| Q1 2021 | $19,284,000 | -11.4% | 1,241,711 | +19.8% | 0.00% | 0.0% |
| Q4 2020 | $21,757,000 | +254.5% | 1,036,117 | +240.8% | 0.00% | – |
| Q3 2020 | $6,137,000 | – | 304,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $103,977,000 | 14.71% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,161,000 | 12.76% |
| Octagon Capital Advisors LP | 481,538 | $10,112,000 | 3.50% |
| Logos Global Management LP | 1,604,392 | $33,692,000 | 2.89% |
| RA Capital Management | 2,805,045 | $58,906,000 | 0.82% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 12,048 | $253,000 | 0.40% |
| HighVista Strategies LLC | 23,760 | $499,000 | 0.32% |
| Vivo Capital, LLC | 315,000 | $6,615,000 | 0.30% |
| Woodline Partners LP | 490,986 | $10,311,000 | 0.27% |
| EcoR1 Capital, LLC | 215,000 | $4,515,000 | 0.24% |